Hadassah

Hadassah’s Young Patients Transported to New Pediatric Intensive Care Unit

Tuesday, May 15 2012

Leaving the crowded Pediatric Intensive Care Unit (PICU) on the fourth floor, the first young patients, on beds and in incubators, were moved into the new spacious PICU three floors above in the Hadassah University Medical Center Charlotte R. Bloomberg Mother and Child Center.

Among the first patients were a 5-year-old girl from an Orthodox Jewish settlement near Jerusalem, who underwent complicated surgery to remove a massive sarcoma tumor from her cheek, and a 15-year-old boy from East Jerusalem who required a complex cardiac operation to rectify a long-term congenital heart defect. Shortly afterward, a 9-day-old baby, born with a complex cardiac anomaly, was transferred directly from the operating theater to the new PICU.

Hadassah's PICU is the principal facility for critically ill newborns through adolescents age 16, from the entire Jerusalem area (population of over one million), who have suffered multiple traumas, neurotrauma, or undergone complicated surgical procedures. Hadassah is a leader in pediatric cardiology and cardiac surgery, neurosurgery, and hemato-oncology. During 2011, 475 patients were hospitalized in Hadassah's PICU--a significant increase from 371 patients in 2010. The average stay was 5.5 days, ranging from 1 day to 3 weeks.

The new eight-bed PICU includes fully separated patient bays with electronically activated transparent glass doors, which control infection and avoid the spread of antibiotic-resistant bacteria. Sophisticated electronic systems enable Hadassah's professional staff to monitor young patients from every location in the PICU—whether near the patient's bedside, at the nursing stations or in staff offices.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Feb 14 2018

Student with MS Running the Jerusalem Marathon to Support Hadassah’s MS Program

Thanks to his physicians at the Hadassah Medical Center, Dov Guggenheim, who was diagnosed with Multiple Sclerosis (MS) in 2015, has gone from “depressed to optimistic, paralyzed to athletic, and, most important, hopeless to hopeful.”

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Texas Tropical Disease Expert Meets with Hadassah Infectious Disease Specialists

Dr. Peter Jay Hotez, renowned professor in the Departments of Pediatrics and Molecular Virology and Microbiology at Houston (Texas) Baylor College of Medicine and Dean of its National School of Tropical Medicine, met with two Hadassah Medical Organization infectious disease specialists to discuss regional cooperation in fighting tropical diseases, such as the now-infamous Zika virus and leishmaniosis, which is contracted from sand flies.

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Large Hadassah Study Identifies Predictor of Greater Risk of End-Stage Renal Disease

The findings of a nationwide study of over a million and a half Israeli adolescents, conducted by researchers at the Hadassah-Hebrew University Braun School of Public Health and Community Medicine, suggest that kidney disease in childhood is associated with a significantly increased risk of end-stage renal disease (ESRD) in adulthood, even if kidney function seems normal in adolescence.

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Israeli Start-up’s Algorithm Predicts Which Diabetic Patients Will Suffer Kidney Dysfunction Within One Year

The Israeli start-up Medial EarlySign has created a machine-learning-based model that has proven to identify diabetic patients who are at the highest risk for experiencing renal dysfunction within one year.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More